View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry


What to Expect at Immuno-Oncology 360° 2018

  • September 26, 2017

  • Immuno-Oncology 360° is a comprehensive program providing exposure to the entire spectrum of R&D, addressing key aspects from all facets of IO including:


    • Discovery / Preclinical Science
    • Translational Science
    • Clinical Development
    • Business Aspects
    • Investor Relations
    • Emerging Technologies
    • Biomarkers / Diagnostics
    • Trends in the Field

    Dr Axel Hoos, GSK and Dr James Gulley, NCI, together led the design of the 4th Annual Immuno-Oncology 360° program to include 45 speakers and over 30 talks. Save the date: February 7-9, 2018 in New York City.